| Roche Pharma (Schweiz) AG - Phesgo 600 mg/600 mg/10 ml, Injektionslösung | | 67828 | | 01 | | Phesgo 600 mg/600 mg/10 ml | | Injektionslösung | | L01FY01 | | | | 08.04.2021 | | |
| | Composition | | pertuzumabum 600 mg, trastuzumabum 600 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, trehalosum dihydricum, saccharum, polysorbatum 20, dl-methioninum, aqua ad iniectabile q.s. ad solutionem pro 10 ml. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Pertuzumabum | 600mg / 10ml | | Trastuzumab | 600mg / 10ml |
| | BAG: Active Agent | Dose |
|---|
| Pertuzumabum | 600 mg | | Trastuzumab | 600 mg |
| | | | Inactive agents |
|---|
| DL-Methionine | | Histidin Hydrochloride Monohydrate | | Histidine | | Hyaluronidasum Humanum Adnr | | Polysorbatum 20 | | Saccharum | | Trehalosum Dihydricum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 3313.89 | 3620.45 | A | SL | No |
|
|
